LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

Company Performance - LifeMD, Inc. reported a quarterly loss of $0.06 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.02, representing an earnings surprise of -200.00% [1] - The company posted revenues of $62.22 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 6.02%, but showing an increase from $50.66 million in the same quarter last year [2] - Over the last four quarters, LifeMD has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - LifeMD shares have increased approximately 149.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $67.5 million, and for the current fiscal year, it is $0.04 on revenues of $268.15 million [7] Industry Outlook - The Medical Services industry, to which LifeMD belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact LifeMD's stock performance [5]